Education
About Us
Working with TipRanks
Follow Us
Viva Biotech Holdings (HK:1873)
:1873
RESEARCH TOOLSreports
1873 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.47 - HK$2.12
Previous CloseN/A
Volume129.00K
Average Volume (3M)6.15M
Market Cap
HK$3.23B
Enterprise ValueHK$3.21B
Total Cash (Recent Filing)HK$941.58M
Total Debt (Recent Filing)¥1.28B
Price to Earnings (P/E)18.8
Beta2.28
Next Earnings
Aug 28, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jun 16, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding2,128,434,300
10 Day Avg. Volume6,490,304
30 Day Avg. Volume6,149,321
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)1.01
Price to Sales (P/S)0.00
P/FCF Ratio119.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$1.50Price Target Upside1.35% Upside
Rating ConsensusHold
Number of Analyst Covering0
Viva Biotech Holdings News
PremiumCompany Announcements
Viva Biotech Clarifies Details on Connected Transaction with Nanjing Entities
PremiumCompany Announcements
Viva Biotech Enters Joint Venture to Launch Pharmaceutical Investment Fund
PremiumCompany Announcements
Viva Biotech Holdings Announces Annual General Meeting with Key Resolutions
PremiumCompany Announcements
Viva Biotech Holdings Announces Board Composition and Committee Roles
PremiumCompany Announcements
Viva Biotech Reports Improved Profitability Amid Revenue Decline
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.28%
Mutual Funds
0.01% Other Institutional Investors
99.65% Public Companies and
Individual Investors
1873 FAQ
What was Viva Biotech Holdings’s price range in the past 12 months?
Viva Biotech Holdings lowest stock price was HK$0.47 and its highest was HK$2.12 in the past 12 months.
What is Viva Biotech Holdings’s market cap?
Viva Biotech Holdings’s market cap is HK$3.23B.
When is Viva Biotech Holdings’s upcoming earnings report date?
Viva Biotech Holdings’s upcoming earnings report date is Aug 28, 2025 which is in 40 days.
How were Viva Biotech Holdings’s earnings last quarter?
Currently, no data Available
Is Viva Biotech Holdings overvalued?
According to Wall Street analysts Viva Biotech Holdings’s price is currently Undervalued.
Does Viva Biotech Holdings pay dividends?
Viva Biotech Holdings pays a Notavailable dividend of HK$0.01 which represents an annual dividend yield of N/A. See more information on Viva Biotech Holdings dividends here
What is Viva Biotech Holdings’s EPS estimate?
Viva Biotech Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Viva Biotech Holdings have?
Viva Biotech Holdings has 2,128,434,300 shares outstanding.
What happened to Viva Biotech Holdings’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Viva Biotech Holdings?
Currently, no hedge funds are holding shares in HK:1873
Viva Biotech Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
218.00%
12-Months-Change
Fundamentals
Return on Equity
4.47%
Trailing 12-Months
Asset Growth
-8.52%
Trailing 12-Months
Company Description
Viva Biotech Holdings
Viva Biotech Holdings (stock code: 1873) is a China-based company primarily engaged in providing drug discovery services to biotechnology and pharmaceutical companies worldwide. The company operates in the sectors of Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), offering a wide range of integrated services including structure-based drug discovery, medicinal chemistry, and drug development services. Viva Biotech leverages its proprietary technology platforms and experienced scientific team to accelerate the drug discovery process for its clients.
Technical Analysis
Shanghai Henlius Biotech, Inc. Class H
―
Lepu Biopharma Co. Ltd. Class H
―
Shanghai Junshi Biosciences Co., Ltd. Class H
―